Leukemia, Myeloid  >>  cyclosporine  >>  Phase 3
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclosporine / Generic mfg.
NCT00002789: Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myeloid Leukemia

Completed
3
100
US
busulfan, cyclophosphamide, cyclosporine, methotrexate, allogeneic bone marrow transplantation, peripheral blood stem cell transplantation
Fred Hutchinson Cancer Center, National Cancer Institute (NCI)
Leukemia
09/01
09/01
NCT00002456: Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation

Completed
3
US
cyclosporine, methotrexate, allogeneic bone marrow transplantation
Fred Hutchinson Cancer Center
Graft Versus Host Disease, Leukemia, Lymphoma
 
04/02
A BMT Study, NCT00005866: S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia

Completed
3
240
US, Canada
busulfan, cyclophosphamide, cyclosporine, methotrexate, allogeneic bone marrow transplantation, radiation therapy
Southwest Oncology Group, National Cancer Institute (NCI)
Leukemia, Myelodysplastic Syndromes
03/04
03/06
NCT00003187: Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma

Completed
2/3
19
US
filgrastim, cyclophosphamide, cyclosporine, cytarabine, methotrexate, methylprednisolone, allogeneic bone marrow transplantation, in vitro-treated bone marrow transplantation, radiation therapy
Virginia Commonwealth University, National Cancer Institute (NCI)
Leukemia, Lymphoma, Myelodysplastic Syndromes
02/05
02/05

Download Options